Hilary R. Keller

425 total citations
22 papers, 281 citations indexed

About

Hilary R. Keller is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Hilary R. Keller has authored 22 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Hilary R. Keller's work include Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (12 papers) and Immune Cell Function and Interaction (10 papers). Hilary R. Keller is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (12 papers) and Immune Cell Function and Interaction (10 papers). Hilary R. Keller collaborates with scholars based in United States, South Korea and Germany. Hilary R. Keller's co-authors include Jung‐Hyun Park, Megan A. Luckey, Changwan Hong, Xuguang Tai, Davinna L. Ligons, James W. Wells, Helmut Schaider, Li Li, Xin Zhang and Grace Kim and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Hilary R. Keller

17 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hilary R. Keller United States 12 185 115 63 23 21 22 281
Rebecca P. Emmons United States 7 296 1.6× 97 0.8× 81 1.3× 13 0.6× 9 0.4× 9 424
Adnan Deronic Sweden 10 195 1.1× 126 1.1× 98 1.6× 17 0.7× 15 0.7× 14 289
Kangling Xu United States 3 174 0.9× 130 1.1× 81 1.3× 7 0.3× 9 0.4× 7 309
Jenny Landsberg Germany 7 81 0.4× 124 1.1× 102 1.6× 9 0.4× 14 0.7× 7 227
Juan‐Manuel Hernandez‐Martinez Mexico 6 164 0.9× 168 1.5× 71 1.1× 13 0.6× 8 0.4× 13 318
Edgar Montes-Servín Mexico 7 196 1.1× 171 1.5× 58 0.9× 13 0.6× 10 0.5× 15 324
Rikke B. Holmstroem Denmark 6 143 0.8× 197 1.7× 61 1.0× 16 0.7× 11 0.5× 10 280
Yunbin Ye China 7 143 0.8× 124 1.1× 97 1.5× 24 1.0× 24 1.1× 16 284
Hongyan Huang China 6 120 0.6× 130 1.1× 122 1.9× 16 0.7× 17 0.8× 8 271
Sébastien Trop Canada 10 251 1.4× 112 1.0× 130 2.1× 8 0.3× 9 0.4× 13 322

Countries citing papers authored by Hilary R. Keller

Since Specialization
Citations

This map shows the geographic impact of Hilary R. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilary R. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilary R. Keller more than expected).

Fields of papers citing papers by Hilary R. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilary R. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilary R. Keller. The network helps show where Hilary R. Keller may publish in the future.

Co-authorship network of co-authors of Hilary R. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Hilary R. Keller. A scholar is included among the top collaborators of Hilary R. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilary R. Keller. Hilary R. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Can, Davinna L. Ligons, Hilary R. Keller, et al.. (2025). Integrin CD103 expression in naive CD8+ T cells promotes cytokine-driven acquisition of memory phenotype and effector function. Immunity. 58(11). 2734–2752.e9.
2.
Li, Can, Megan A. Luckey, Hilary R. Keller, et al.. (2025). Integrin CD103 reveals a distinct developmental pathway of autoreactive thymocytes in TCR transgenic mice. Nature Communications. 16(1). 6627–6627.
3.
Keller, Hilary R., et al.. (2025). Metastatic Melanoma Outcomes and the Evolving Role of Surgery in the Immunotherapy Era. JAMA Surgery. 160(9). 1026–1026.
4.
Keller, Hilary R., et al.. (2022). Survival in patients with neuroendocrine tumors of the colon, rectum and small intestine. The American Journal of Surgery. 225(1). 58–65. 7 indexed citations
5.
Keller, Hilary R., Davinna L. Ligons, Can Li, et al.. (2021). The molecular basis and cellular effects of distinct CD103 expression on CD4 and CD8 T cells. Cellular and Molecular Life Sciences. 78(15). 5789–5805. 11 indexed citations
6.
7.
Waickman, Adam T., Hilary R. Keller, Tae‐Hyoun Kim, et al.. (2020). The Cytokine Receptor IL-7Rα Impairs IL-2 Receptor Signaling and Constrains the In Vitro Differentiation of Foxp3+ Treg Cells. iScience. 23(8). 101421–101421. 15 indexed citations
8.
Luckey, Megan A., Praveen Prakhar, Hilary R. Keller, et al.. (2020). SOCS3 is a suppressor of γc cytokine signaling and constrains generation of murine Foxp3 + regulatory T cells. European Journal of Immunology. 50(7). 986–999. 8 indexed citations
9.
Keller, Hilary R., Hye Kyung Kim, Yuna Jo, et al.. (2020). The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells. The Journal of Immunology. 204(12). 3227–3235. 11 indexed citations
10.
Keller, Hilary R., et al.. (2018). Multiple Endocrine Neoplasia Type 1: A Case Report With Review of Imaging Findings. Ochsner Journal. 18(2). 170–175.
11.
Keller, Hilary R., Xin Zhang, Li Li, Helmut Schaider, & James W. Wells. (2017). Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma. Oncotarget. 8(43). 75675–75686. 43 indexed citations
12.
Ologun, Gabriel O, et al.. (2017). Natural History Of an Untreated Type 1 Endoleak: A Case Report . Cureus. 9(7). e1507–e1507.
13.
Hong, Changwan, Megan A. Luckey, Davinna L. Ligons, et al.. (2014). Activated T Cells Secrete an Alternatively Spliced Form of Common γ-Chain that Inhibits Cytokine Signaling and Exacerbates Inflammation. Immunity. 40(6). 910–923. 43 indexed citations
14.
Park, Joo‐Young, Hilary R. Keller, Noriko Sato, & Jung‐Hyun Park. (2014). NKT cells require IL-7, not IL-15, for survival and homeostasis (LYM4P.761). The Journal of Immunology. 192(Supplement_1). 65.18–65.18. 4 indexed citations
15.
Hong, Changwan, Anna S. Nam, Hilary R. Keller, et al.. (2013). Interleukin-6 expands homeostatic space for peripheral T cells. Cytokine. 64(2). 532–540. 12 indexed citations
16.
Ligons, Davinna L., Anna S. Nam, Changwan Hong, et al.. (2013). Pim1 permits generation and survival of CD4+T cells in the absence of γc cytokine receptor signaling. European Journal of Immunology. 43(9). 2283–2294. 13 indexed citations
17.
Ligons, Davinna L., Ceren Tuncer Şakar, Sema Kurtuluş, et al.. (2012). CD8 Lineage-specific Regulation of Interleukin-7 Receptor Expression by the Transcriptional Repressor Gfi1. Journal of Biological Chemistry. 287(41). 34386–34399. 17 indexed citations
18.
Kim, Grace, Davinna L. Ligons, Changwan Hong, et al.. (2012). An In Vivo IL-7 Requirement for Peripheral Foxp3+ Regulatory T Cell Homeostasis. The Journal of Immunology. 188(12). 5859–5866. 25 indexed citations
19.
Hirsch, Théo Z., et al.. (1998). Analysis of the T Cell Receptor Variability of Tumor-Infiltrating Lymphocytes in Colorectal Carcinomas. Tumor Biology. 19(3). 205–212. 25 indexed citations
20.
Keller, Hilary R., et al.. (1997). Expression of CD44, ICAM-1 and N-CAM in colorectal cancer. Correlation with the tumor stage and the phenotypical characteristics of tumor-infiltrating lymphocytes.. PubMed. 17(4A). 2395–400. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca P. Emmons Breakdown of academic impact, for papers by Adnan Deronic Breakdown of academic impact, for papers by Kangling Xu Breakdown of academic impact, for papers by Jenny Landsberg Breakdown of academic impact, for papers by Juan‐Manuel Hernandez‐Martinez Breakdown of academic impact, for papers by Edgar Montes-Servín Breakdown of academic impact, for papers by Rikke B. Holmstroem Breakdown of academic impact, for papers by Yunbin Ye Breakdown of academic impact, for papers by Hongyan Huang Breakdown of academic impact, for papers by Sébastien Trop
Rankless by CCL
2026